"FDA Endorses New Covid Vaccine for Fall 2024"
TL;DR Summary
An FDA advisory panel has recommended updating Covid vaccines for the fall to target the JN.1 variant or its descendants to prevent a potential winter surge. The FDA will soon decide which strain to target, prompting vaccine production for a fall campaign. Pfizer, Moderna, and Novavax are preparing updated vaccines, with Pfizer and Moderna ready by mid-August. Covid hospitalizations are low, but cases may be rising slightly. A CDC advisory group will later recommend who should get the fall vaccine.
- Will there be a new Covid vaccine in the fall? NBC News
- FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall CNN
- FDA panel supports switch to JN.1 for fall COVID vaccines University of Minnesota Twin Cities
- COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say Reuters
- Novavax Says It Can Deliver Recommended Covid Vaccine in September MarketWatch
Reading Insights
Total Reads
0
Unique Readers
18
Time Saved
3 min
vs 4 min read
Condensed
88%
656 → 80 words
Want the full story? Read the original article
Read on NBC News